Cargando…
The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
The novel coronavirus disease 2019 (COVID-19) pandemic has imposed significant public health problems for the human populations worldwide after the 1918 influenza A virus (IVA) (H1N1) pandemic. Although numerous efforts have been made to unravel the mechanisms underlying the coronavirus, a notable g...
Autores principales: | Mirzaei, Rasoul, Mahdavi, Farzad, Badrzadeh, Fariba, Hosseini-Fard, Seyed Reza, Heidary, Maryam, Jeda, Ali Salimi, Mohammadi, Tayeb, Roshani, Mahdane, Yousefimashouf, Rasoul, Keyvani, Hossein, Darvishmotevalli, Mohammad, Sani, Melika Zarei, Karampoor, Sajad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664359/ https://www.ncbi.nlm.nih.gov/pubmed/33221169 http://dx.doi.org/10.1016/j.intimp.2020.107204 |
Ejemplares similares
-
Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine
por: Mirzaei, Rasoul, et al.
Publicado: (2020) -
The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19)
por: Mirzaei, Rasoul, et al.
Publicado: (2021) -
Correction to: The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID‑19)
por: Mirzaei, Rasoul, et al.
Publicado: (2021) -
The emerging role of exosomal miRNAs as a diagnostic and therapeutic biomarker in Mycobacterium tuberculosis infection
por: Mirzaei, Rasoul, et al.
Publicado: (2021) -
Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments
por: Goodarzi, Pedram, et al.
Publicado: (2020)